TY - JOUR
T1 - Labour force participation among individuals with hepatitis C in the US
AU - Jacobs, Philip
AU - NG, Ying Chu
AU - Stafinski, Tania
AU - Dodd, Roger
AU - Larke, Bryce
AU - Wong, Winnie
N1 - Funding Information:
We acknowledge the help and advice of Mitchell Halper-in, Nadine MacLean, Gerald Minuk, Julia Uhanova, and Don Sin in the preparation of this manuscript. This paper is based on a project that was partly funded by Health Canada. The authors have provided no information on conflicts of interest directly relevant to the content of this study.
PY - 2003
Y1 - 2003
N2 - Background: In 1996, the number of persons newly infected with hepatitis C virus (HCV) in the US was estimated to be 36 000. As a chronic disease that primarily affects younger persons, hepatitis C has the potential to influence employment considerably. Objective: To estimate employment effects associated with hepatitis C morbidity. Design: An economic model of labour supply, which used the outcome measure workforce participation (yes/no), was applied. Study participants: The study samples (by gender) were comprised of persons 18-65 years of age, with and without serological evidence of HCV infection, and with normal or elevated levels of alanine aminotransferase (ALT) who participated in the National Health and Nutrition Examination Survey III from 1988-1994. Results: After controlling for the potential confounding effects of demographic, social, and economic factors, positive HCV status/normal ALT level in males was associated with a 10.7% reduction in labour force participation (when compared with negative HCV status). Positive HCV status and elevated ALT levels was associated with a 17.5% reduction in employment. The results for females were not statistically significant. Conclusions: Nationally, the employment response for HCV-positive status and elevated ALT levels translates into an excess non-employment of 48 000 males annually.
AB - Background: In 1996, the number of persons newly infected with hepatitis C virus (HCV) in the US was estimated to be 36 000. As a chronic disease that primarily affects younger persons, hepatitis C has the potential to influence employment considerably. Objective: To estimate employment effects associated with hepatitis C morbidity. Design: An economic model of labour supply, which used the outcome measure workforce participation (yes/no), was applied. Study participants: The study samples (by gender) were comprised of persons 18-65 years of age, with and without serological evidence of HCV infection, and with normal or elevated levels of alanine aminotransferase (ALT) who participated in the National Health and Nutrition Examination Survey III from 1988-1994. Results: After controlling for the potential confounding effects of demographic, social, and economic factors, positive HCV status/normal ALT level in males was associated with a 10.7% reduction in labour force participation (when compared with negative HCV status). Positive HCV status and elevated ALT levels was associated with a 17.5% reduction in employment. The results for females were not statistically significant. Conclusions: Nationally, the employment response for HCV-positive status and elevated ALT levels translates into an excess non-employment of 48 000 males annually.
UR - http://www.scopus.com/inward/record.url?scp=0037495970&partnerID=8YFLogxK
U2 - 10.2165/00019053-200321080-00003
DO - 10.2165/00019053-200321080-00003
M3 - Journal article
C2 - 12751914
AN - SCOPUS:0037495970
SN - 1170-7690
VL - 21
SP - 565
EP - 572
JO - PharmacoEconomics
JF - PharmacoEconomics
IS - 8
ER -
